Kratom (), an indigenous medicinal plant of Southeast Asia, is believed to be harmful. We compared the perceptions toward kratom use among kratom users and non-users in Malaysia. 356 respondents (137 kratom users and 219 non-users) were recruited for this cross-sectional study. The majority of respondents were male (60%, n = 212/356), Malays (88%), and 51% were ≥37 years old. Non-users showed higher unadjusted odds of reporting a perception that kratom use can cause addiction (OR = 6.72, CI: 3.91-11.54, < .0001), withdrawal symptoms (OR = 7.58, CI: 4.62-12.42, < .0001), illicit drug use problems (OR = 10.12, CI: 6.14-16.68, < .0001), impaired social-functioning (OR = 12.05, CI: 7.24-20.05, < .0001), and health problems (OR = 10.44, CI: 6.32-17.24, < .0001). Similarly, non-users viewed kratom policies differently from kratom users, displaying increased odds of reporting the belief that kratom use and sales must be regulated with stringent laws (OR = 5.75, CI: 3.61-9.18, < .0001), and kratom should be regulated instead under the Dangerous Drugs Act 1952 to overcome kratom use problems (OR = 8.26, CI: 4.94-13.82, < .0001). Because of the disconnect in kratom use perceptions and personal experiences between kratom users and non-users, hastily criminalizing kratom without investigating carefully its scientific merits can significantly impede future kratom research.

Download full-text PDF

Source
http://dx.doi.org/10.1080/02791072.2020.1738603DOI Listing

Publication Analysis

Top Keywords

perceptions kratom
8
kratom users
8
kratom
6
public perceptions
4
kratom malaysia
4
malaysia kratom
4
kratom indigenous
4
indigenous medicinal
4
medicinal plant
4
plant southeast
4

Similar Publications

Kratom is a widely used Asian botanical that has gained popularity in the United States due to a perception that it can treat pain, anxiety, and opioid withdrawal symptoms. The American Kratom Association estimates 10-16 million people use kratom. Kratom-associated adverse drug reactions (ADRs) continue to be reported and raise concerns about the safety profile of kratom.

View Article and Find Full Text PDF

Qualitative content analysis of public responses to an FDA inquiry on the impact of scheduling changes to kratom.

Int J Drug Policy

October 2022

Department of Pharmacology and Toxicology, College of Medicine, University of Arkansas for Medical Sciences, 4301 W. Markham Street, Mail Slot 611, Little Rock, AR 72205, USA.

Background: The legal status of kratom in the United States is complex and varies by state. The U.S.

View Article and Find Full Text PDF

There is limited understanding regarding kratom use among US adults. Although motivations for use are increasingly understood, typical kratom doses, threshold of (low and high) doses for perceived effectiveness, and effects produced during cessation are not well documented. We aimed to extend prior survey work by recruiting adults with current and past kratom exposure.

View Article and Find Full Text PDF

Kratom: An Emerging Issue and Need for Regulations in the United States.

Prim Care Companion CNS Disord

February 2021

Department of Psychiatry, Griffin Memorial Hospital, Norman, Oklahoma.

Objective: To understand and highlight the current issues, emerging trends, and regulations of kratom in the United States.

Data Sources: PubMed and PubMed Central of the National Library of Medicine, MEDLINE, PsycINFO, and ClinicalTrials.gov databases were utilized.

View Article and Find Full Text PDF

: Kratom has a long history of traditional medicine use in Southeast Asia. Consumption of kratom products has also been reported in the US and other regions of the world. Pain relief is among many self-reported kratom effects but have not been evaluated in controlled human subject research.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!